Search
for
Sort by
Research 61–90 of 1000+
- Vitamin D, Lipid Metabolism and Prostate Cancer
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- The eye and the skin in endocrine metabolic diseases
- 272 Structural changes in human skin after topical application of glucocorticoids assessed by in vivo imaging technologies
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Role of skin enzymes in metabolism of topical drugs
- Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?
- Metabolic syndrome in alopecia areata: an observational study at a tertiary care center
- Evaluation of metabolic and hormonal parameters in women with PCOS living in Black Sea Region
- Clinical aspects of the metabolic syndrome
- Comparison of Components of Metabolic Syndrome in Androgenic Alopecia versus Healthy Population
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- The effect of minocycline on the metabolism of androgens by human oral periosteal fibroblasts and its inhibition by finasteride
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Comparison of metformin and N-acetylcysteine on metabolic parameters in women with polycystic ovarian syndrome
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes
- Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Glucocorticoids Influencing Wnt/β-Catenin Pathway; Multiple Sites, Heterogeneous Effects
- Cross‐sectional relation of long‐term glucocorticoids in hair with anthropometric measurements and their possible determinants: A systematic review and meta‐analysis
- Hormone therapy in acne